Price target
346.440.000.00%
The 7 analysts offering 1 year price forecasts for TLX1/N have a max estimate of — and a min estimate of —.
Analyst rating
Based on 10 analysts giving stock ratings to TLX1/N in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
TLX1/N EPS for the last quarter is 1.07 MXN despite the estimation of 1.65 MXN. In the next quarter EPS is expected to reach 1.20 MXN. Track more of TELIX PHARMACEUTIC financials and stay on top of what is up with the company.
In the next quarter TELIX PHARMACEUTIC revenue is expected to reach 5.29 B MXN. Check out TELIX PHARMACEUTIC revenue and earnings and make informed decisions.
According to analysts, TLX1/N price target is 346.44 MXN with a max estimate of 440.03 MXN and a min estimate of 284.57 MXN. Check if this forecast comes true in a year, meanwhile watch TELIX PHARMACEUTIC stock price chart and keep track of the current situation with TLX1/N news and stock market news.
We've gathered opinions of 10 analysts rating TLX1/N stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.